Growing Caseload, Applications, Active Companies and Markets in Sealants/Glues, Wound Closure Market

Growth in use of sealants, glues, hemostasis, wound closure and anti-adhesion is being driven by many factors, including physician adoption, applications, products, companies and worldwide market penetration. New MedMarket Diligence report (#S175).
By: MedMarket Diligence
 
Jan. 26, 2009 - PRLog -- The steady rate of adoption by physicians using novel wound closure, hemostasis and anti-adhesion products, the growing caseload to which products are being applied, the proliferation of companies developing and introducing products and the expanding international markets for them are collectively responsible for the high growth in the market for these products.

The "Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2009-2013," is detailed in a new report from MedMarket Diligence. The report is described at http://www.mediligence.com/rpt/rpt-s175.htm.

A rapidly growing number of companies is active in surgical sealants, glues, hemostasis and anti-adhesion:

3DM, Inc. (3D-Matrix, Ltd.), 3M, Abbott Vascular, AccessClosure, Inc., Adhezion Biomedical, LLC, Advanced Medical Solutions plc, Allerderm, Angiotech Pharmaceuticals, Inc., Anika Therapeutics, Inc., ARC Pharmaceuticals, Arch Therapeutics, Inc., ArthroCare Corporation, Aso LLC, Aspen Surgical Products, Atrax Medical Group, Avery Dennison, B. Braun Melsungen AG, Bastos Viegas, s.a., Baxter International Inc., Bayer HealthCare, BD (Becton, Dickinson and Company), Berlin Heart GmbH, Bernsco Surgical Supply, Biocoral Inc., BioCore Medical Technologies, Inc., Biogentis, Inc., Biomet Inc., BIOSTER a.s., BioSyntech Canada Inc., BSN Medical, C.R. Bard, Cardiovascular Sciences, Inc., Carl Auffarth GmbH & Co. KG, Cardiva Medical, Inc., Ceremed, Inc., Chemence Ltd., Chemopharma, s.a., Cohera Medical, Inc., Collagen Matrix, Inc., Coloplast A/S, ConvaTec, Covidien Ltd., CryoLife Inc., CSIRO PhotoMedical Technologies, CSL Behring, CSMG Technologies, Inc., CuraMedical BV, Cypress Medical Products, Derma Sciences, Inc., Distrex Ibérica S.A., DuPont Applied BioSciences, Entegrion, Inc., FibroGen, Inc., Fidia Advanced Biopolymers, Flamel Technologies SA, Forticell Bioscience, FzioMed Inc., Gelita Medical BV, GEM srl, Genzyme Biosurgery Inc., GluStitch, Inc., Graceduty Company Limited, GramsMed, LLC, Haemacure Corporation, HAPTO Biotech Israel Ltd., Hartmann Group, Harvest Technologies Corporation, HemCon Medical Technologies, Inc., Hemostasis, LLC, HyperBranch Medical Technology, Inc., Incisive Surgical, Inc., Innovasa Corporation, Integra Lifesciences Corporation, I-Therapeutix, Inc., Johnson & Johnson, Kaketsuken (Chemo-Sero-Therapeutic Research Institute), Kensey Nash Corporation, Kimberly-Clark Health Care, Kinetic Concepts, Inc., King Pharmaceuticals, Inc., Kookbo Chemicals Co., Ltd. (KB Chem.), Laboratoires Urgo (Urgo Medical), Lewis Medical Supplies, LifeBond Ltd., Lifecore Biomedical, Inc., Lohmann & Rauscher, Marine Polymer Technologies, Medafor, Inc., Medi Surgichem Pvt. Ltd., MedTrade Products, Ltd., Meyer-Haake GmbH Medical Innovations, Mölnlycke Health Care AB, Morris Innovative, Motex Healthcare Corp., Myco Medical, NeatStitch Ltd., Neose Technologies Inc. (Novo Nordisk), Nycomed, Omrix Biopharmaceuticals Inc., Pac-Kit Safety Equipment, Pfizer Inc., Pharming Group NV, Plasma Technologies, Inc., PlasmaSeal, Pluromed, Inc., Polyganics, Polyheal Ltd., ProFibrix BV, Progressive Surgical, Ltd., Protein Polymer Technologies, Inc., Radi Medical Systems AB, Resorba Wundversorgung GmbH & Co. KG, Scapa Group plc, Scion Cardio-Vascular, Inc., Sea Run Holdings, Seton, Smith & Nephew plc, Starch Medical, Inc., Stereoplast Ltd., Sutura, Inc., Synovis Life Technologies, SyntheMed, Inc., Teleflex Medical, ThermoGenesis Corporation, Therus Corporation, Thrombotargets Corp., Tissuemed Ltd., TraumaCure, Inc., TyRx Pharma Inc., Vascular Solutions, Inc., Vectura Group plc, Vivostat A/S, Z-Medica Corporation, Zimmer, ZymoGenetics, Inc.

The MedMarket Diligence report #S175, "Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2009-2013," is a market and technology assessment and forecast of products in wound closure. The report details the current and emerging products, technologies and markets involved in wound closure and sealing using sutures and staples, tapes, hemostats, fibrin and sealant products, medical adhesives and products to prevent post-surgical adhesions. The report provides a worldwide current and annual forecast to 2013 of the markets for these technologies, with particular emphasis on the market impact of new technologies through the coming decade.  The report provides specific forecasts and shares of the worldwide market by segment for the U.S., Europe (United Kingdom, German, France, Italy, BeNeLux), Latin America, Japan and Rest of World. 

The report provides background data on the surgical, disease and traumatic wound patient populations targeted by current technologies and those under development, and the current clinical practices in the management of these patients, including the dynamics among the various clinical specialties or subspecialties vying for patient population and facilitating or limiting the growth of technologies. 

The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast. The report also assesses and projects the composition of the market as technologies gain or lose relative market performance over this period. 

For more details on this report, including description, table of contents, list of exhibits and ordering information, see http://www.mediligence.com/rpt/rpt-s175.htm.

The report may be purchased online at https://www.mediligence.com/store/page29.html.

MedMarket Diligence provides tactical decision-making solutions on medical technology to the medical products and investment industries. The company publishes dedicated reports on medical technology markets and offers the Medtech Startups Database on hundreds of newly founded medtech companies.

# # #

MedMarket Diligence provides data and insight to the medical products, investment and other industries on advanced medical technologies through focused medical technology market and assessment Reports and the Medtech Startups Database.
End
Source:MedMarket Diligence
Email:***@mediligence.com Email Verified
Zip:92610
Tags:Fibrin Glue, Fibrin Sealant, Surgical Glue, Surgical Sealant, Hemostasis, Anti-adhesion, Sutures, Surgical Staples
Industry:Business, Medical, Health
Location:California - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
MedMarket Diligence, LLC News
Most Viewed
Most Viewed Monthly



Like PRLog?
9K2K1K
Click to Share